Mouse models of different hotspot mutp53 proteins and clinical data from germline and sporadic cancers have established that some mutp53 proteins not only abolish the wild-type (wt) p53 tumor suppressive function, but can become oncogenic, promoting invasion, metastasis, and chemoresistance [3,4]. This evidence concerns the gene TP53 and neoplasm.